Positive Health Online
Your Country
![[Image: http://www.abundanceandhealth.co.uk]](/img/original/BannerAvatar/2836.df7d2315253110ff5b3a566f94871f99.jpg "http://www.abundanceandhealth.co.uk")
![[Image: https://www.water-for-health.co.uk/]](/img/original/BannerAvatar/4046.12831f50177f8848ee87b8e94411d6b3.jpg "https://www.water-for-health.co.uk/")
![[Image: http://www.balens.co.uk]](/img/original/BannerAvatar/2148.50367fa908013fae0a7f1a171543ef92.jpg "http://www.balens.co.uk")
![[Image: http://www.drsgoodman.com/books-goodman/52-nutrition-and-cancer]](/img/original/BannerAvatar/1859.1296090fd8385e7ceff51c8011559097.jpg "http://www.drsgoodman.com/books-goodman/52-nutrition-and-cancer")
Research: ELATTAR and VIRJI,
Listed in Issue 43
Abstract
ELATTAR and VIRJI, Hormone Research Laboratory, University of Missouri-Kansas City, School of Dentistry 64108 USA researched the effect of treating human tongue cancer cells with vitamin E .
Background
Methodology
The authors treated human tongue squamous carcinoma cell SCC-25 with physiological concentrations of vitamin E succinate (VES), varying from 0.001 to 50 micromoles/L.
Results
Treatment with vitamin E in concentrations of 0.001 to 50 micromoles/L resulted in significant dose-dependent stimulation of cell growth, whereas pharmacological doses of vitamin E (100-154 micromoles/L) induced significant inhibition of cell growth.
Conclusion
References
Elattar TM and Virji AS Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells. Anticancer Research 19(1A): 365-8. Jan-Feb 1999.
